Interferon in the treatment of ovarian cancer.
Welander
C E
CE
Department of Obstetrics and Gynecology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC.
D000970:Antineoplastic Agents / Q000008:administration & dosage; D001201:Ascites / Q000209:etiology / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007370:Interferon Type I / Q000008:administration & dosage; D007371:Interferon-gamma / Q000008:administration & dosage; D007372:Interferons / Q000008:administration & dosage*; D010051:Ovarian Neoplasms / Q000150:complications / Q000628:therapy*
D000970:Antineoplastic Agents; D007370:Interferon Type I; D007371:Interferon-gamma; D007372:Interferons